Precipio Inc
$ 23.97
2.17%
07 Aug - close price
- Market Cap 41,967,500 USD
- Current Price $ 23.97
- High / Low $ 25.04 / 23.34
- Stock P/E N/A
- Book Value 7.94
- EPS -0.46
- Next Earning Report 2026-08-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.06 %
- ROE -0.07 %
- 52 Week High 33.63
- 52 Week Low 13.80
About
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
Analyst Target Price
$19.00
Quarterly Earnings
| Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-18 | 2025-11-14 | 2025-08-13 | 2025-05-14 | 2025-03-27 | 2024-11-06 | 2024-08-13 | 2024-05-14 | 2023-11-13 | 2023-08-11 | 2023-05-12 | 2023-03-30 |
| Reported EPS | -0.8093 | -0.05 | 0.05 | -0.5883 | -0.2444 | -0.4229 | -0.8336 | 0.6514 | -1.04 | -1.8 | -2.6 | -0.1 |
| Estimated EPS | None | None | None | None | 0.74 | None | None | None | -1.4 | -2 | -2.6 | -0.14 |
| Surprise | 0 | 0 | 0 | 0 | -0.9844 | 0 | 0 | 0 | 0.36 | 0.2 | 0 | 0.04 |
| Surprise Percentage | None% | None% | None% | None% | -133.027% | None% | None% | None% | 25.7143% | 10% | 0% | 28.5714% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-12 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PRPO
2026-08-05 00:41:58
This article analyzes Precipio Inc. (NASDAQ: PRPO) using AI models to generate trading strategies across different risk profiles. Key findings indicate divergent sentiment, suggesting choppy conditions, and highlights support and resistance levels. The analysis provides specific entry, target, and stop-loss zones for position trading, momentum breakout, and risk hedging strategies.
2026-08-02 20:10:54
Precipio (PRPO) announced it will host its Q2 2026 shareholder update call on August 17, 2026, at 5:00 p.m. ET to discuss performance in its cancer diagnostics businesses. CEO Ilan Danieli will provide remarks on progress and engage in a live Q&A session. TipRanks' AI Analyst, Spark, rates PRPO as Neutral, citing improving financials but noting negative net income and mixed technical positioning.
2026-08-01 04:43:11
Precipio Inc (PRPO) has a weak financial status with a score of 4.51, ranking 199 out of 200 in its industry. Despite this, the company reported a significant year-over-year revenue increase of 36.15% and a net profit increase of 63.24% in its latest quarter. Key financial metrics such as cash and cash equivalents, operating profit, and free cash flow were not disclosed, indicating a lack of transparency or available data.
2026-08-01 03:40:13
Precipio, Inc. (NASDAQ: PRPO) announced it will host a Q2-2026 shareholder update call on August 17, 2026, at 5:00 PM ET. The call will cover updates on the company's core businesses and include a live moderated Q&A session. CEO Ilan Danieli expressed optimism about progress in customer acquisition, pipeline expansion, and business growth, which will be reflected in the upcoming Q2 results.
2026-08-01 01:40:13
Precipio Inc. has scheduled its Q2-2026 shareholder update call for August 17, 2026, at 5:00 PM ET. CEO Ilan Danieli will discuss core business updates and progress in customer acquisition and pipeline expansion. Investors can participate in a live Q&A session or submit questions in advance, with a replay available online shortly after the call.
2026-07-31 05:11:16
This article provides a risk assessment for Precipio Inc (PRPO), detailing its current risk score of 2.96 within the Healthcare Equipment & Supplies industry. It highlights the company's beta value of 1.33, indicating higher volatility compared to the S&P 500. The assessment also covers various metrics including VaR, maximum drawdown, volatility, return performance, Sharpe Ratio, skewness, and liquidity.
